Pivotal bioVenture Partners Investment Advisor LLC Long-Term Concentrated

CIK: 0001844645 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 16, 2021

Total Value ($000): $253,722 (100.0% shares, 0.0% debt)

Holdings (8)

— KARUNA THERAPEUTICS INC 38.3%

Value ($000) $97,200 Shares 852,708 Est. Cost $101.59 Unrealized —

PCVX VAXCYTE INC 12.5%

Value ($000) $31,636 Shares 1,405,421 Est. Cost $37.18 Unrealized -44.9%

— BOLT BIOTHERAPEUTICS INC 11.5%

Value ($000) $29,242 Shares 1,891,467 Est. Cost $32.91 Unrealized —

— INOZYME PHARMA INC 10.7%

Value ($000) $27,113 Shares 1,591,154 Est. Cost $20.64 Unrealized —

— AKOUOS INC 8.9%

Value ($000) $22,516 Shares 1,794,088 Est. Cost $19.83 Unrealized —

— ALIGOS THERAPEUTICS INC 7.0%

Value ($000) $17,873 Shares 876,548 Est. Cost $27.65 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 6.1%

Value ($000) $15,529 Shares 569,041 Est. Cost $24.49 Unrealized +15.0%

— FUSION PHARMACEUTICALS INC 5.0%

Value ($000) $12,613 Shares 1,598,377 Est. Cost $11.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	KARUNA THERAPEUTICS INC	852,708	$97,200	38.3%	$101.59	—	COM	48576A100
PCVX	VAXCYTE INC	1,405,421	$31,636	12.5%	$37.18	-44.9%	COM	92243G108
—	BOLT BIOTHERAPEUTICS INC	1,891,467	$29,242	11.5%	$32.91	—	COM	097702104
—	INOZYME PHARMA INC	1,591,154	$27,113	10.7%	$20.64	—	COM	45790W108
—	AKOUOS INC	1,794,088	$22,516	8.9%	$19.83	—	COM	00973J101
—	ALIGOS THERAPEUTICS INC	876,548	$17,873	7.0%	$27.65	—	COM	01626L105
ARQT	ARCUTIS BIOTHERAPEUTICS INC	569,041	$15,529	6.1%	$24.49	+15.0%	COM	03969K108
—	FUSION PHARMACEUTICALS INC	1,598,377	$12,613	5.0%	$11.75	—	COM	36118A100